TLR7 and systemic lupus erythematosus: Recent studies used TLR-7 agonists, such as imiquimod (IMQ) or R848, to induce lupus-like conditions in mice, assessing various treatments’ effects on SLE-related pathologies, including hypertension [27] and lupus nephritis [20].